Search For "clinical trial"
Russian COVID vaccine Sputnik V meets primary safety endpoint in phase-2 c
Updated : 5 years, 2 months ago IST
Hyderabad (Telangana) [India], January 11 (ANI): The Russian made Covid-19 vaccine Sputnik V has met the primary endpoint of safety in the phase-2 clinical trials in India and has been recommended to continue the clinical trial without any modifications, according to an official statement.
Read More
COVID-19: Bharat Biotech enrols 25,800 volunteers for Covaxin phase-3 clin
Updated : 5 years, 2 months ago IST
Hyderabad (Telangana) [India], January 7 (ANI): The Bharat Biotech International Limited on Thursday announced the successful completion of volunteer enrolment for phase-3 clinical trials of its indigenously manufactured COVID-19 vaccine 'Covaxin.'
Read More
Emergency use of vaccine is based on safety, immunogenicity data, says ICM
Updated : 5 years, 2 months ago IST
New Delhi [India], January 5 (ANI): The Indian Council of Medical Research (ICMR) director Dr Balram Bhargava on Tuesday said that in a pandemic situation, restricted emergency use of the vaccine is considered based on phase 2 safety and immunogenicity clinical trial data while phase thre
Read More
Bharat Biotech MD questions experts' silence over UK trials of Covid-19 va
Updated : 5 years, 2 months ago IST
New Delhi [India], January 4 (ANI): Coming down heavily on critics expressing doubts about the Bharat Biotech's indigenously developed coronavirus vaccine COVAXIN, the Hyderabad-based biotech major's managing director Dr Krishna Ella on Monday slammed the critics for targeting Indian clinica
Read More
Zydus Cadila gets DCGI nod for Phase-3 clinical trials for Covid-19 vaccin
Updated : 5 years, 2 months ago IST
New Delhi [India], January 4 (ANI): The drug regulatory body Drugs Controller General of India (DCGI) has approved Ahmedabad based drug firm Zydus Cadila to initiate Phase III clinical trials of its Covid-19 vaccine ZyCoV-D.
Read More
DCGI permission to Covaxin is 'for restricted use in an emergency situatio
Updated : 5 years, 2 months ago IST
New Delhi [India], January 3 (ANI): Drugs Controller General of India (DCGI) on Sunday said the permission given to Bharat Biotech's COVAXIN is "for restricted use in an emergency situation" and it is given in "public interest as an abundant precaution" as the vaccine is still in clinical tr
Read More
ICMR says clinical trial shows COVAXIN is 'safe'
Updated : 5 years, 2 months ago IST
New Delhi [India], January 3 (ANI): Hours after Drugs Controller General of India (DCGI) approved restricted use in an emergency situation to Bharat Biotech's COVID-19 vaccine, Indian Council of Medical Research (ICMR) on Sunday said data generated through pre-clinical studies and various ph
Read More
COVID-19: Bharat Biotech recruits 23,000 volunteers for COVAXIN's phase 3
Updated : 5 years, 2 months ago IST
Hyderabad (Telangana) [India], January 2 (ANI): Bharat Biotech has recruited 23,000 volunteers so far for the Phase III clinical trials of its COVID-19 vaccine candidate, 'COVAXIN'.
Read More
Higher red blood cell transfusions level may cause high risk to premature
Updated : 5 years, 2 months ago IST
Virginia [US], January 1 (ANI): A randomized clinical trial lead by researchers of George Mason University has examined the blood transfusions in premature babies and their long term impacts.
Read More
Government could evaluate AstraZeneca, Covaxin: Dr Vijay Bhaskar
Updated : 5 years, 2 months ago IST
Hyderabad (Telangana) [India], December 31 (ANI): The government could evaluate two vaccines including the indigenously researched Covaxin and AstraZeneca to address the Covid-19 pandemic, Dr Vijay Bhaskar, Chairman of the Ethics Committee, Clinical trials and research said on Thursday.
Read More
AIIMS New Delhi advertises for Phase-III clinical trial of Covaxin
Updated : 5 years, 2 months ago IST
New Delhi [India], December 24 (ANI): The All India Institute of Medical Sciences (AIIMS) based in New Delhi on Thursday invited volunteers for the Phase III clinical trial of the indigenously developed COVID-19 vaccine candidate 'Covaxin' for which it is one of the sites.
Read More
Aurobindo Pharma, Covaxx to develop Covid-19 vaccine for India, UNICEF
Updated : 5 years, 2 months ago IST
Hyderabad (Telangana) [India], December 24 (ANI): Aurobindo Pharma and US-based Covaxx have entered into a license agreement to develop, commercialise and manufacture a vaccine to fight Covid-19 for India and the United Nations Children's Fund (UNICEF) agency.
Read More